Status:
COMPLETED
Topical Application of Latanoprost in Diabetic Retinopathy
Lead Sponsor:
University of Aarhus
Collaborating Sponsors:
Aarhus University Hospital
Conditions:
Diabetic Retinopathy
Eligibility:
All Genders
20-36 years
Phase:
PHASE4
Brief Summary
Randomized double-blinded two-year intervention study with topical application of latanoprost or placebo eye drops in patients with diabetic retinopathy.
Detailed Description
The primary objective is to study if a sustained contraction of pathologically dilated retinal arterioles can be obtained. Retinal arteriolar diameter and the diameter response to increased blood pres...
Eligibility Criteria
Inclusion
- Age 20-36 years old
- Diabetes mellitus with retinopathy
Exclusion
- Pregnancy
- Previous ocular disease other than diabetic retinopathy
- General disease with possible influence on the eye
Key Trial Info
Start Date :
November 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 1 2014
Estimated Enrollment :
27 Patients enrolled
Trial Details
Trial ID
NCT01225653
Start Date
November 1 2010
End Date
December 1 2014
Last Update
December 18 2014
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ophthalmology, Århus University Hospital
Aarhus, Denmark, 8000